Images |
Sources |
Experiment + Assay |
Phenotypes |
Human Diseases |
|
fig.6.c, d
Rothe M et al. (2017)
|
Xla Wt + epha4 MO
NF13 (in situ hybridization)
|
|
|
|
fig.6.g, h
Rothe M et al. (2017)
|
Xla Wt + epha4 MO
NF23 (in situ hybridization)
|
|
|
|
fig.2.g
Rothe M et al. (2017)
|
Xla Wt + epha4 MO
NF37/38 (in situ hybridization)
|
|
|
|
fig.4.g
Rothe M et al. (2017)
|
Xla Wt + epha4 MO
NF37/38 (in situ hybridization)
|
|
|
|
fig.S2.a
Rothe M et al. (2017)
|
Xla Wt + epha4 MO
NF42 (in situ hybridization)
|
|
|
|
fig.S3.a
Rothe M et al. (2017)
|
Xla Wt + epha4 MO
NF42 (real time PCR)
|
|
|
|
fig.S2.b
Rothe M et al. (2017)
|
Xla Wt + epha4 MO
NF42 (RT-PCR)
|
|
|
|
fig.7.f
Rothe M et al. (2017)
|
Xla Wt + nog + epha4 MO + animal cap explant
NF13 (real time PCR)
|
|
|